Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa
Clinical trial NCT02670330 · TERMINATED
Trial details
- NCT number
- NCT02670330
- Sponsor
- Scioderm, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-09
- Primary completion
- 2018-09-03
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.